Related Experiment Videos
Vascular types I and II transforming growth factor-beta receptor expression: differential dependency on tyrosine
M R Ward1, A Agrotis, G Jennings
1Cell Biology Laboratory, Baker Medical Research Institute and Alfred Hospital, Prahran, Vic., Australia. mward@baker.edu.au
Abstract:
Recent evidence indicates that the type II transforming growth factor-beta (TGF-beta) receptor (TbetaRII) is a serine-threonine-tyrosine kinase. However, the significance of its tyrosine kinase is unclear. We investigated in vascular smooth muscle cells the effects of tyrosine kinase inhibition on the expression of TGF-beta receptor types I (ALK-5) and II (TbetaRII) mRNA, induced by TGF-beta1. TGF-beta1 elevated ALK-5 mRNA levels 5-fold; essentially similar TGF-beta1-dependent elevations were observed with growth factors, PDGF-BB and FGF-2. The tyrosine kinase inhibitor genistein abolished these TGF-beta1 and growth factor responses. TGF-beta1 also elevated TbetaRII mRNA levels which were not inhibited by genistein. We conclude that tyrosine kinases participate in defining how cells respond to TGF-beta.
Insights
Tyrosine kinases play a crucial role in how vascular smooth muscle cells respond to transforming growth factor-beta (TGF-beta). Inhibiting these kinases affects TGF-beta receptor expression, highlighting their significance in cellular signaling.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The type II transforming growth factor-beta (TGF-beta) receptor (TbetaRII) possesses serine-threonine-tyrosine kinase activity.
- The specific role of its tyrosine kinase activity in cellular responses remains largely undefined.
Purpose of the Study:
- To investigate the impact of tyrosine kinase inhibition on the expression of TGF-beta receptor types I (ALK-5) and II (TbetaRII) mRNA in vascular smooth muscle cells.
- To elucidate the role of tyrosine kinases in TGF-beta1-induced signaling pathways.
Main Methods:
- Vascular smooth muscle cells were treated with TGF-beta1, PDGF-BB, and FGF-2.
- The effects of the tyrosine kinase inhibitor genistein on receptor mRNA expression were analyzed.
- Quantitative analysis of ALK-5 and TbetaRII mRNA levels was performed.
Main Results:
- TGF-beta1 significantly elevated ALK-5 mRNA levels (5-fold), an effect mimicked by PDGF-BB and FGF-2.
- The tyrosine kinase inhibitor genistein completely abolished these TGF-beta1 and growth factor-induced elevations in ALK-5 mRNA.
- While TGF-beta1 also increased TbetaRII mRNA, this effect was not inhibited by genistein.
Conclusions:
- Tyrosine kinases are integral components in mediating cellular responses to TGF-beta signaling.
- Inhibition of tyrosine kinase activity specifically impacts the expression of the TGF-beta type I receptor (ALK-5), suggesting a selective regulatory mechanism.